SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Lexeo Therapeutics, Inc.
@LXEO_InsiderForm 4 Filing: Tamayo Louis Edward Sells $20,838.09 of $LXEO
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Lexeo Therapeutics, Inc.
Ticker: $LXEO
Transaction Value
$20,838.09
Price/Share: $1.25
transaction date
2026-07-01
Shares: 16,641
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Tamayo Louis Edward, holds the title of Chief Financial Officer at Lexeo Therapeutics, Inc..
On 2026-07-01, the insider transacted 16,641 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $20,838.09.
Executive Summary Summary
Tamayo Louis Edward (Chief Financial Officer) sold $21K of $LXEO
Post-Transaction Position: 97,024 shares
SEC Accession No: 0002083206-26-000005 (CIK: 2083206)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.